These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7429449)

  • 1. An assessment program to reduce drug use with the mentally retarded.
    Fielding LT; Murphy RJ; Reagan MW; Peterson TL
    Hosp Community Psychiatry; 1980 Nov; 31(11):771-3. PubMed ID: 7429449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing psychotropic drug use in an institution for the retarded.
    LaMendola W; Zabaria ES; Carver M
    Hosp Community Psychiatry; 1980 Apr; 31(4):271-2. PubMed ID: 7390422
    [No Abstract]   [Full Text] [Related]  

  • 3. Considerations in the use of psychotropic drugs in elderly mentally retarded persons.
    Aman MG
    J Ment Defic Res; 1990 Feb; 34 ( Pt 1)():1-10. PubMed ID: 2182880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and drug use in mentally retarded, emotionally disturbed adults.
    Matson JL; Kazdin AE; Senatore V
    Appl Res Ment Retard; 1984; 5(4):513-9. PubMed ID: 6151823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of and determinants for psychotropic drug use in an institution for the mentally retarded.
    Linaker OM
    Br J Psychiatry; 1990 Apr; 156():525-30. PubMed ID: 1974820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the prescription of psychotropic drugs (1970-1977) in a state hospital.
    Craig TJ; Behar R
    Compr Psychiatry; 1980; 21(5):336-45. PubMed ID: 7418377
    [No Abstract]   [Full Text] [Related]  

  • 7. Ventricular enlargement in adults with profound mental retardation who demonstrate violent/destructive behaviors.
    May PB; DeMarco K; London EB; Thompson R; Mento TL; Buscemi L; Cody R
    J Neuropsychiatry Clin Neurosci; 2001; 13(1):96-100. PubMed ID: 11207335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of BR-16 A (Mentat) in cognitive and behavioural dysfunction of mentally retarded children--a placebo-controlled study.
    Dave UP; Chauvan V; Dalvi J
    Indian J Pediatr; 1993; 60(3):423-8. PubMed ID: 8253492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a psychotropic drug review service in a mental retardation facility.
    Marcoux AW
    Hosp Pharm; 1985 Nov; 20(11):827-31. PubMed ID: 10274172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic drug use in older developmentally disabled with behavioral difficulties.
    Harper DC; Wadsworth JS; Michael AL
    Res Dev Disabil; 1989; 10(1):53-60. PubMed ID: 2928579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacologic interventions in agitated mentally retarded patients].
    Sidoun P; Hillel J; Grunberg F; Elie R
    Can J Psychiatry; 1989 Feb; 34(1):63-8. PubMed ID: 2647272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research in mental retardation: underreporting of medication information.
    Agran M; Moore S; Martin JE
    Res Dev Disabil; 1988; 9(4):351-7. PubMed ID: 3205936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring drugs in hospitals for the mentally handicapped.
    James DH
    Br J Psychiatry; 1983 Feb; 142():163-5. PubMed ID: 6839070
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing patterns of psychoactive drug use with the mentally retarded.
    White AJ
    N Z Med J; 1983 Sep; 96(739):686-8. PubMed ID: 6577342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of psychotropic drug, response cost, and psychotropic drug plus response cost procedures for controlling institutionalized mentally retarded persons.
    Breuning SE; O'Neill MJ; Ferguson DG
    Appl Res Ment Retard; 1980; 1(3-4):253-68. PubMed ID: 7337461
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
    Schützwohl M; Voss E; Stiawa M; Salize HJ; Puschner B; Koch A
    Nervenarzt; 2017 Nov; 88(11):1273-1280. PubMed ID: 27638741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Training psychiatric residents in the diagnosis and treatment of mental illness in mentally retarded persons.
    Menolascino FJ; Fleisher MH
    Hosp Community Psychiatry; 1992 May; 43(5):500-3. PubMed ID: 1587515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of problem behaviour during medication evaluations.
    Zarcone J; Napolitano D; Valdovinos M
    J Intellect Disabil Res; 2008 Dec; 52(12):1015-28. PubMed ID: 18717764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practitioner versus medication-expert opinion on psychiatric pharmacotherapy of mentally retarded patients with mental disorders.
    Patel NC; Crismon ML; Rush AJ; Frances A
    Am J Health Syst Pharm; 2001 Oct; 58(19):1824-9. PubMed ID: 11596698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of psychotropic and anti-epileptic drug use in mentally handicapped students].
    Meins W
    Z Kinder Jugendpsychiatr; 1991 Mar; 19(1):15-8. PubMed ID: 1927052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.